Peapack Gladstone Financial Increased By $875.65 Million Its Merck & Co (MRK) Holding; Osi Systems (OSIS)’s Sentiment Is 1.24

October 13, 2017 - By Adrian Mccoy

OSI Systems, Inc., through its subsidiaries, is a vertically integrated designer and maker of specialized electronic systems and components for critical applications. The company has market cap of $1.80 billion. The Firm sells its products and provides related services in diversified markets, including homeland security, healthcare, defense and aerospace. It has a 88.26 P/E ratio.

Peapack Gladstone Financial Corp increased Merck & Co Inc (MRK) stake by 3.57% reported in 2017Q2 SEC filing. Peapack Gladstone Financial Corp acquired 13,663 shares as Merck & Co Inc (MRK)’s stock declined 2.46%. The Peapack Gladstone Financial Corp holds 396,758 shares with $25.43B value, up from 383,095 last quarter. Merck & Co Inc now has $173.68B valuation. The stock increased 0.08% or $0.05 during the last trading session, reaching $63.83. About shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since October 13, 2016 and is uptrending. It has outperformed by 0.16% the S&P500.

Among 20 analysts covering Merck & Co. Inc. (NYSE:MRK), 15 have Buy rating, 1 Sell and 4 Hold. Therefore 75% are positive. Merck & Co. Inc. had 53 analyst reports since August 13, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Hold” rating in Friday, April 15 report. Jefferies maintained the shares of MRK in report on Tuesday, March 15 with “Hold” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Underperform” rating given on Monday, December 19 by Jefferies. Credit Suisse maintained the shares of MRK in report on Monday, May 9 with “Neutral” rating. UBS maintained the shares of MRK in report on Friday, August 19 with “Buy” rating. The firm has “Buy” rating given on Tuesday, November 17 by Argus Research. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Sell” rating by Jefferies on Thursday, May 25. The stock has “Sell” rating by Jefferies on Monday, July 17. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating on Friday, August 18. Jefferies has “Sell” rating and $52.0 target. JP Morgan maintained Merck & Co., Inc. (NYSE:MRK) on Monday, September 21 with “Overweight” rating.

Peapack Gladstone Financial Corp decreased Ishares Russell Midcap Etf (IWR) stake by 40 shares to 11,860 valued at $2.28 billion in 2017Q2. It also reduced Aon Plc (NYSE:AON) stake by 372 shares and now owns 71,660 shares. Biogen Inc (NASDAQ:BIIB) was reduced too.

Investors sentiment increased to 1.07 in 2017 Q2. Its up 0.08, from 0.99 in 2017Q1. It increased, as 56 investors sold MRK shares while 612 reduced holdings. 111 funds opened positions while 603 raised stakes. 1.95 billion shares or 0.77% less from 1.96 billion shares in 2017Q1 were reported. Marshall Wace Limited Liability Partnership invested 0.06% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Assetmark holds 0.03% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 41,292 shares. Heritage Mngmt Corp has 0.95% invested in Merck & Co., Inc. (NYSE:MRK). Private Harbour & Counsel Lc reported 18,963 shares or 1% of all its holdings. Stevens First Principles Invest Advisors reported 0.04% in Merck & Co., Inc. (NYSE:MRK). Smith Salley & Associates reported 92,147 shares or 1.19% of all its holdings. First Dallas owns 11,460 shares or 0.54% of their US portfolio. Tower Bridge Advsr owns 118,306 shares for 0% of their portfolio. Yhb Investment Advsrs stated it has 0.23% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Bridger Llc reported 2.9% of its portfolio in Merck & Co., Inc. (NYSE:MRK). 21,499 were reported by Meristem Ltd Liability Partnership. Dearborn Limited Liability Corporation reported 1.34% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Axa holds 0.37% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 1.26 million shares. Moreover, Mycio Wealth Prns has 0.16% invested in Merck & Co., Inc. (NYSE:MRK) for 20,235 shares. Verition Fund Mngmt Limited Liability Corp holds 0.06% in Merck & Co., Inc. (NYSE:MRK) or 9,981 shares.

The stock increased 0.46% or $0.44 during the last trading session, reaching $95.76. About shares traded. OSI Systems, Inc. (OSIS) has risen 56.65% since October 13, 2016 and is uptrending. It has outperformed by 39.95% the S&P500.

Analysts await OSI Systems, Inc. (NASDAQ:OSIS) to report earnings on October, 26. They expect $0.70 EPS, up 59.09% or $0.26 from last year’s $0.44 per share. OSIS’s profit will be $13.16M for 34.20 P/E if the $0.70 EPS becomes a reality. After $1.02 actual EPS reported by OSI Systems, Inc. for the previous quarter, Wall Street now forecasts -31.37% negative EPS growth.

Ratings analysis reveals 100% of OSI Systems’s analysts are positive. Out of 2 Wall Street analysts rating OSI Systems, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. OSIS was included in 2 notes of analysts from November 16, 2016. The rating was initiated by Drexel Hamilton on Wednesday, November 16 with “Buy”. The rating was initiated by Jefferies on Wednesday, April 12 with “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>